Viewing Study NCT00298350


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2026-04-27 @ 11:45 AM
Study NCT ID: NCT00298350
Status: COMPLETED
Last Update Posted: 2008-07-29
First Post: 2006-02-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV View
None HIV-1 View
None Human Immunodeficiency Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 2 View
None Phase II View
None Randomized View
None Controlled View
None Comparator View
None Partially Blind View
None Protease Inhibitors View
None Integrase Inhibitors View
None Antiviral Agents View
None Antiretroviral Agents View
None ART View
None ARV View
None Highly Activity Antiretroviral Therapy View
None HAART View
None Treatment Experienced View